Session Details

S045 Updates in Cutaneous Oncology

Sun, Mar 10, 1:00 PM - 4:00 PM
Room 24C
3 CME Available Symposium
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Dermatologists’ knowledge is essential to the improvement of diagnosis and management of pediatric and adult patients with skin cancers. A multi-disciplinary panel with expertise in pediatric and adult oncodermatology, cutaneous lymphomas, Mohs surgery, and surgical oncology will provide a high-yield review of pathophysiology, state-of-the-art diagnostic studies, and discuss therapeutic strategies in cutaneous oncology patients. This session is targeted to dermatologists, residents, and practitioners involved in the care of cutaneous oncology patients

LEARNING OBJECTIVES

1.

Outline updates in pathogenesis of non-melanoma skin cancers, Merkel cell carcinoma, melanoma, and cutaneous T-cell lymphomas

2.

Discuss the latest molecular, histopathological, and imaging studies that aid in the diagnosis of cutaneous oncology patients

3.

Identify novel therapeutic approaches and formulate management strategies for adult and pediatric patients with non-melanoma skin cancers, Merkel cell carcinoma, melanoma and cutaneous T-cell lymphomas

SCHEDULE

8:00 PM

Welcome and Introduction

Lucia Seminario-Vidal, MD, PhD, FAAD

8:05 PM

Cutaneous Squamous Cell Carcinoma Update

Jayne S Joo, MD, FAAD

8:35 PM

Basal Cell Carcinoma: Review and Updates/

Allison Weinkle, MD, FAAD

9:05 PM

CTCL: Cases and Early Stage Treatment

Stephen Malachowski, MD, MS, FAAD

9:35 PM

Panel: Questions And Discussion

Lucia Seminario-Vidal, MD, PhD, FAAD, Jayne S Joo, MD, FAAD, Stephen Malachowski, MD, MS, FAAD, Allison Weinkle, MD, FAAD

9:50 PM

Update on the Latest Advances in Treatment of Melanoma

Vernon Sondak, MD

10:20 PM

Updates in Merkel Cell Carcinoma

David Miller, MD, PhD, FAAD

10:50 PM

Panel: Questions And Discussion

David Miller, MD, PhD, FAAD, Vernon Sondak, MD, Kenneth Y. Tsai, MD, PhD, FAAD

SPEAKERS

Jayne S Joo, MD, FAAD

Jayne S Joo, MD, FAAD

Stephen Malachowski, MD, MS, FAAD

Stephen Malachowski, MD, MS, FAAD

David Miller, MD, PhD, FAAD

David Miller, MD, PhD, FAAD

Lucia Seminario-Vidal, MD, PhD, FAAD

Lucia Seminario-Vidal, MD, PhD, FAAD

Vernon Sondak, MD

Vernon Sondak, MD

Kenneth Y. Tsai, MD, PhD, FAAD

Kenneth Y. Tsai, MD, PhD, FAAD

Allison Weinkle, MD, FAAD

Allison Weinkle, MD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Jayne S Joo, MD, FAAD

No financial relationships exist with ineligible companies.

Stephen Malachowski, MD, MS, FAAD

No financial relationships exist with ineligible companies.

David Miller, MD, PhD, FAAD

Castle Biosciences – Advisory Board(Stock); Checkpoint Therapeutics – Advisory Board(Honoraria); EMD Serono – Advisory Board(Honoraria); Kartos Therapeutics – Investigator(Grants/Research Funding); Merck – Advisory Board(Honoraria); NeoImmuneTech – Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria); Regeneron – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Advisory Board(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); Xilio Therapeutics – Investigator(Grants/Research Funding);

Lucia Seminario-Vidal, MD, PhD, FAAD

Eli Lilly and Company – Employee(Salary), Employee(Stock);

Vernon Sondak, MD

Alkermes – Consultant(Honoraria); Bristol-Myers Squibb – Consultant(Honoraria), Data Safety Monitoring Board(Honoraria); Genesis Drug Discovery & Development – Consultant(Honoraria); Iovance Biotherapeutics – Consultant(Honoraria); Merck – Advisory Board(Honoraria); Neogene Therapeutics – Other(Grants/Research Funding); Novartis – Advisory Board(Honoraria); OncoSec – Advisory Board(Honoraria); Regeneron – Advisory Board(Honoraria); SkylineDx B.V. – Investigator(Grants/Research Funding); STATKING – Consultant(Honoraria); Turnstone Biologics – Investigator(Grants/Research Funding); Ultimovacs – Consultant(Honoraria);

Kenneth Y. Tsai, MD, PhD, FAAD

3CC - Third Culture Capital – Stockholder(No Compensation Received); Altos Labs – Consultant (1099 relationship)(Fees); APIS Assay Technologies – Independent Contractor(Grants/Research Funding); DX Biosciences, Inc – Consultant(Stock Options); Incyte Corporation – Investigator(Grants/Research Funding); NFlection Therapeutics, Inc – Consultant(Fees); UpToDate – Independent Contractor(Fees); Verrica Pharmaceuticals Inc – Independent Contractor(Fees);

Allison Weinkle, MD, FAAD

AbbVie – Investigator(No Compensation Received); TEOXANE Laboratories – Investigator(No Compensation Received);